Dendritic cells as vectors for therapy (Q34339199)

1 August 2017

1 reference

title

Dendritic cells as vectors for therapy (English)

1 reference

1 August 2017

1 reference

1

Banchereau J

1 reference

1 August 2017

Schuler-Thurner B

2

1 reference

1 August 2017

Palucka AK

series ordinal

3

1 reference

1 August 2017

Schuler G

series ordinal

4

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

1 August 2017

1 reference

1 August 2017

106

1 reference

1 August 2017

271-274

1 reference

1 August 2017

3

1 reference

Immunobiology of dendritic cells

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2801%2900448-2

7 January 2021

Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2801%2900448-2

7 January 2021

CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2801%2900448-2

7 January 2021

Mature dendritic cells boost functionally superior CD8(+) T-cell in humans without foreign helper epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2801%2900448-2

7 January 2021

Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2801%2900448-2

7 January 2021

Dendritic cells in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2801%2900448-2

7 January 2021

Dendritic cells injected via different routes induce immunity in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2801%2900448-2

7 January 2021

The makings of a tumor rejection antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2801%2900448-2

7 January 2021

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2801%2900448-2

7 January 2021

Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2801%2900448-2

7 January 2021

Dendritic cells resurrect antigens from dead cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2801%2900448-2

7 January 2021

Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2801%2900448-2

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2801%2900448-2

7 January 2021

Modulating the immune response with dendritic cells and their growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2801%2900448-2

7 January 2021

B cells inhibit induction of T cell-dependent tumor immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2801%2900448-2

7 January 2021

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2801%2900448-2

7 January 2021

Clinical trial designs for the early clinical development of therapeutic cancer vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2801%2900448-2

7 January 2021

The dendritic cell system and its role in immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2801%2900448-2

7 January 2021

NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2801%2900448-2

7 January 2021

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2801%2900448-2

7 January 2021

10.1016/S0092-8674(01)00448-2

Identifiers

DOI

1 reference

release_ba6cy6wyyjeuxjufdwfrroax2a

1 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ba6cy6wyyjeuxjufdwfrroax2a

24 November 2022

mapped directly with Wikidata item

1 reference